Splicing-accessible coding 3'UTRs control protein stability and interaction networks.

3′UTR Alternative open reading frame Alternative splicing Genome structure Protein disorder Protein stability Protein-protein interaction

Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
29 07 2020
Historique:
received: 29 03 2020
accepted: 14 07 2020
entrez: 31 7 2020
pubmed: 31 7 2020
medline: 9 7 2021
Statut: epublish

Résumé

3'-Untranslated regions (3'UTRs) play crucial roles in mRNA metabolism, such as by controlling mRNA stability, translation efficiency, and localization. Intriguingly, in some genes the 3'UTR is longer than their coding regions, pointing to additional, unknown functions. Here, we describe a protein-coding function of 3'UTRs upon frameshift-inducing alternative splicing in more than 10% of human and mouse protein-coding genes. 3'UTR-encoded amino acid sequences show an enrichment of PxxP motifs and lead to interactome rewiring. Furthermore, an elevated proline content increases protein disorder and reduces protein stability, thus allowing splicing-controlled regulation of protein half-life. This could also act as a surveillance mechanism for erroneous skipping of penultimate exons resulting in transcripts that escape nonsense mediated decay. The impact of frameshift-inducing alternative splicing on disease development is emphasized by a retinitis pigmentosa-causing mutation leading to translation of a 3'UTR-encoded, proline-rich, destabilized frameshift-protein with altered protein-protein interactions. We describe a widespread, evolutionarily conserved mechanism that enriches the mammalian proteome, controls protein expression and protein-protein interactions, and has important implications for the discovery of novel, potentially disease-relevant protein variants.

Sections du résumé

BACKGROUND
3'-Untranslated regions (3'UTRs) play crucial roles in mRNA metabolism, such as by controlling mRNA stability, translation efficiency, and localization. Intriguingly, in some genes the 3'UTR is longer than their coding regions, pointing to additional, unknown functions. Here, we describe a protein-coding function of 3'UTRs upon frameshift-inducing alternative splicing in more than 10% of human and mouse protein-coding genes.
RESULTS
3'UTR-encoded amino acid sequences show an enrichment of PxxP motifs and lead to interactome rewiring. Furthermore, an elevated proline content increases protein disorder and reduces protein stability, thus allowing splicing-controlled regulation of protein half-life. This could also act as a surveillance mechanism for erroneous skipping of penultimate exons resulting in transcripts that escape nonsense mediated decay. The impact of frameshift-inducing alternative splicing on disease development is emphasized by a retinitis pigmentosa-causing mutation leading to translation of a 3'UTR-encoded, proline-rich, destabilized frameshift-protein with altered protein-protein interactions.
CONCLUSIONS
We describe a widespread, evolutionarily conserved mechanism that enriches the mammalian proteome, controls protein expression and protein-protein interactions, and has important implications for the discovery of novel, potentially disease-relevant protein variants.

Identifiants

pubmed: 32727563
doi: 10.1186/s13059-020-02102-3
pii: 10.1186/s13059-020-02102-3
pmc: PMC7392665
doi:

Substances chimiques

3' Untranslated Regions 0
RNA Splice Sites 0
Cyclic Nucleotide Phosphodiesterases, Type 6 EC 3.1.4.35
PDE6G protein, human EC 3.1.4.35

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

186

Références

Structure. 2003 Nov;11(11):1453-9
pubmed: 14604535
Curr Opin Cell Biol. 2012 Jun;24(3):323-32
pubmed: 22465326
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5429-34
pubmed: 20212158
Science. 2000 Mar 24;287(5461):2204-15
pubmed: 10731134
Science. 2003 Feb 14;299(5609):1061-4
pubmed: 12511654
Plant Mol Biol. 2004 Aug;55(6):869-81
pubmed: 15604722
J Biol Chem. 2011 Nov 4;286(44):38478-38487
pubmed: 21917930
Protein Eng Des Sel. 2004 Feb;17(2):175-82
pubmed: 15047914
Science. 2008 Jun 20;320(5883):1643-7
pubmed: 18566288
F1000Res. 2013 Feb 07;2:35
pubmed: 24358889
Nat Genet. 2018 Jun;50(6):783-789
pubmed: 29785014
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1505-10
pubmed: 18230733
Nat Genet. 2008 Dec;40(12):1413-5
pubmed: 18978789
Nat Methods. 2006 Mar;3(3):175-7
pubmed: 16489333
Science. 2012 Dec 21;338(6114):1587-93
pubmed: 23258890
Nature. 2015 Jun 18;522(7556):363-7
pubmed: 25896326
Am J Hum Genet. 2010 Aug 13;87(2):258-64
pubmed: 20655036
Mol Cell. 2014 May 22;54(4):651-62
pubmed: 24837677
Nucleic Acids Res. 2016 Feb 29;44(4):1483-95
pubmed: 26773057
Cell. 2015 Mar 12;160(6):1111-24
pubmed: 25768907
Neuron. 2018 May 2;98(3):495-511.e6
pubmed: 29656876
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
PLoS One. 2014 May 13;9(5):e97336
pubmed: 24824035
Genome Biol. 2015 Sep 14;16:179
pubmed: 26364619
Sci Rep. 2015 Jun 22;5:11476
pubmed: 26098304
Science. 1996 May 17;272(5264):1026-9
pubmed: 8638127
Nat Commun. 2019 Nov 1;10(1):5009
pubmed: 31676752
Cell. 2009 Feb 20;136(4):777-93
pubmed: 19239895
EMBO J. 2009 Nov 18;28(22):3613-22
pubmed: 19798052
Science. 2020 Mar 6;367(6482):1140-1146
pubmed: 32139545
Biotechnol Adv. 2012 Jan-Feb;30(1):4-15
pubmed: 21740962
Elife. 2014 Oct 16;3:
pubmed: 25321392
Nature. 2001 Feb 22;409(6823):1071-7
pubmed: 11234020
Genes Dev. 2010 Nov 1;24(21):2343-64
pubmed: 21041405
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):189-92
pubmed: 12502788
Cell. 2009 Aug 21;138(4):673-84
pubmed: 19703394
Nature. 2015 Apr 2;520(7545):90-3
pubmed: 25807486
Cell. 2018 Nov 29;175(6):1492-1506.e19
pubmed: 30449617
Nat Rev Mol Cell Biol. 2018 Jan;19(1):20-30
pubmed: 29018283
Nature. 2011 May 19;473(7347):337-42
pubmed: 21593866
Cell Rep. 2014 Sep 25;8(6):1832-1844
pubmed: 25220455
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Cell. 2016 Feb 11;164(4):805-17
pubmed: 26871637
Cell Mol Life Sci. 2012 Nov;69(21):3613-34
pubmed: 22538991
Elife. 2014 Aug 27;3:e03346
pubmed: 25163748
Nature. 2016 Jun 30;534(7609):719-23
pubmed: 27281202
Nat Commun. 2018 Jun 6;9(1):2189
pubmed: 29875359
Nature. 2010 May 6;465(7294):53-9
pubmed: 20445623

Auteurs

Marco Preussner (M)

Institute of Chemistry and Biochemistry, Freie Universität Berlin, Laboratory of RNA Biochemistry, Takustrasse 6, 14195, Berlin, Germany.

Qingsong Gao (Q)

Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Laboratory for Systems Biology and Functional Genomics, Robert-Rössle-Str. 10, 13125, Berlin, Germany.

Eliot Morrison (E)

Institute of Chemistry and Biochemistry, Freie Universität Berlin, Laboratory of Protein Biochemistry, Thielallee 63, 14195, Berlin, Germany.

Olga Herdt (O)

Institute of Chemistry and Biochemistry, Freie Universität Berlin, Laboratory of RNA Biochemistry, Takustrasse 6, 14195, Berlin, Germany.

Florian Finkernagel (F)

Center for Tumor Biology and Immunology (ZTI), Philipps-University Marburg, Hans-Meerwein-Straße 3, 35043, Marburg, Germany.

Michael Schumann (M)

Leibniz-Institut für Molekulare Pharmakologie, Robert-Rössle-Strasse 10, 13125, Berlin, Germany.

Eberhard Krause (E)

Leibniz-Institut für Molekulare Pharmakologie, Robert-Rössle-Strasse 10, 13125, Berlin, Germany.

Christian Freund (C)

Institute of Chemistry and Biochemistry, Freie Universität Berlin, Laboratory of Protein Biochemistry, Thielallee 63, 14195, Berlin, Germany.

Wei Chen (W)

Department of Biology, South University of Science and Technology of China, Shenzhen, Guangdong, China. chenw@sustech.edu.cn.

Florian Heyd (F)

Institute of Chemistry and Biochemistry, Freie Universität Berlin, Laboratory of RNA Biochemistry, Takustrasse 6, 14195, Berlin, Germany. florian.heyd@fu-berlin.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH